In 2022, in honor of his 70th birthday, the International Cannabinoid Research Society (ICRS) established the ICRS Ethan Russo Trainee Prize—a community-funded scholarship awarded annually to an outstanding ICRS trainee conducting applied, translational research with phytochemicals and direct applications in medicine. The Prize both recognizes Dr. Russo’s profound contributions to cannabinoid science and invests in the next generation of researchers carrying that work forward.

We are pleased to invite you to a special webinar where Dr. Ethan Russo will introduce the two most recent recipients of the ICRS Ethan Russo Trainee Prize, who will present their prize-winning research.

• Beth Wiese, PhD
  “Cannabidiol treatment to prevent opioid overdose mortality”
• Radka Kocvarova, PhD
  “Phytocannabinoids for treating obesity-related fatty liver disease”

Webinar details
📅 Tuesday, March 10
⏰ 1:00 pm EST | 10:00 am PST
📍 Zoom

While there is no cost to attend, we invite you to consider supporting the future of translational cannabinoid medicine by contributing $25 (or more) to the Ethan Russo Trainee Prize Fund in lieu of a registration fee. Your donation directly supports early-career scientists conducting rigorous research with real-world medical impact—ensuring that innovative cannabinoid therapeutics continue to move from bench to bedside, potentially transforming patient care worldwide.

Together, we can celebrate scientific excellence, amplify emerging voices in the field, and invest in the research that will shape the future of cannabinoid-based medicine.

Please join us for our next webinar, “Critical Gaps in Cannabis & Endocannabinoid System Education: Deficiencies in Medical Training & Necessary Curriculum Reform for Future Clinicians“

This FREE webinar is a must-attend for physicians, nurses, researchers, and cannabis science enthusiasts. However, please note that space is limited and registration is on a first-come, first-served basis.

We are proud to announce that we have joined forces with our education partner, MM411, and sponsors, Global Cannabis Network Collective, American Cannabis Nurses Association, and the Society of Cannabis Clinicians, to bring you this essential webinar.

Join us as Dr. Ethan Russo presents solutions to findings from recent publications that examine whether medical professionals are receiving adequate training and education about cannabis and the endocannabinoid system. Dr. Russo will also highlight critical topics that physicians and researchers believe should be included in medical and nursing education.

As noted by Liz Sherer in a recent article published in MedScape, “There are 19 cannabis education certificate and/or master’s level programs offered in colleges, universities, and graduate schools in 14 US states, meaning that only about one third of the 48 states that have legalized medicinal cannabis have some sort of college or graduate-level curriculum to support patients. The dearth of cannabis education has also left a large percentage of the more than 1 million practicing physicians in the US — and concurrently, most future prescribers — without a framework to leverage what has the potential to become one of the most important tools at their disposal.”

It is alarming to consider that nearly 35 years after the discovery of the endocannabinoid system—the system responsible for maintaining health and homeostasis, regulating, modulating, and playing a role in every biological function in the body—it is STILL not being included in medical school curricula.

In this webinar, we will explore what is missing from nursing and medical school education and discuss what should be included. This promises to be another very interesting and enlightening session.

Dr. Ethan Russo will be discussing:

• A new article from a Delphi panel of 23 experts outlines recommendation for cannabis and ECS education
• Discussing the gaps in current approaches
• Presenting a new online educational platform

This webinar will take place Thursday, October 9th, 2025, 11am PST/ 2pm EST on Zoom. It is free to attend.

Please join us for our next webinar, “Update on ALS: Amyotrophic Lateral Sclerosis, Cannabis, and Hope for the Future”.

The webinar will cover:

1) ALS is a terminal condition in which the motor neurons (nerves to the muscles) slowly deteriorate.
2) Despite decades of research, no breakthrough conventional treatments have emerged.
3) Various cannabis components target underlying pathology in ALS and offer the promise of palliatively treating its many symptoms.

This seminar is FREE to those who register via Zoom.